fosfestrol and Liver-Neoplasms

fosfestrol has been researched along with Liver-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for fosfestrol and Liver-Neoplasms

Article	Year
[Primary, nonviral, hepatocellular carcinoma in patients with prostate cancer treated by hormone therapy: 2 case reports]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2005, Volume: 96, Issue:4 We studied two cases of primary, hepatocellular carcinoma (HCC) that occurred following hormone therapy (estrogen therapy in one case and total androgen blockade therapy in another) for stage D2 prostate cancer. Prostate cancer is considered to be hormone-dependent, and androgens appear to be important hormonal factors. However, hepatocellular carcinoma has been shown to have both estrogen and androgen receptors, suggesting that this may be dependent on estrogen or androgen. Reported here are two unique cases of hepatocellular carcinoma in patients with prostate cancer; the pathogenesis of HCC in these patients was suspected to be related to diethylstilbestrol (DES) therapy and antiandrogen therapy for their prostate cancer. Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Carcinoma, Hepatocellular; Diethylstilbestrol; Drug Administration Schedule; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Prostatic Neoplasms	2005

Article

Year

[Primary, nonviral, hepatocellular carcinoma in patients with prostate cancer treated by hormone therapy: 2 case reports].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2005, Volume: 96, Issue:4

We studied two cases of primary, hepatocellular carcinoma (HCC) that occurred following hormone therapy (estrogen therapy in one case and total androgen blockade therapy in another) for stage D2 prostate cancer. Prostate cancer is considered to be hormone-dependent, and androgens appear to be important hormonal factors. However, hepatocellular carcinoma has been shown to have both estrogen and androgen receptors, suggesting that this may be dependent on estrogen or androgen. Reported here are two unique cases of hepatocellular carcinoma in patients with prostate cancer; the pathogenesis of HCC in these patients was suspected to be related to diethylstilbestrol (DES) therapy and antiandrogen therapy for their prostate cancer.

Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Carcinoma, Hepatocellular; Diethylstilbestrol; Drug Administration Schedule; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Prostatic Neoplasms

2005